Highlights and key clinical trial updates from ASCO GI 2022 Published 2022-02-15 Download video MP4 360p Recommendations 02:12 A Phase II trial: dostarlimab alone for the treatment of dMMR locally advanced rectal cancer 42:33 The NCI Li Fraumeni Syndrome Study: Ongoing Work to Guide Tailored Care 02:32 Choosing efficacious treatment options for hepatocellular carcinoma 06:06 Ravi's Bladder Cancer Story 02:20 ORCHESTRA: tumor debulking in metastatic colorectal cancer 1:15:24 SFA Education Session: ASCO Review 2024 02:32 CARACO: Lymphadenectomies in advanced ovarian cancer 01:05 The emerging role of ctDNA in liver cancer management 01:07 Development of patient-accessible therapeutics for HCC 00:45 Bridging techniques in the treatment of resectable HCC 29:03 Interview with Peer Mentor Falline Danforth 00:40 Neoadjuvant sacituzumab govitecan for muscle-invasive bladder cancer 00:48 Role of predictive biomarkers in patients with MIBC 00:32 Adverse effects of ramucirumab plus paclitaxel for HER2- G/GEJ cancer 34:12 Keynote-522 Similar videos 00:51 Key clinical trial updates from ASCO GI 2023 00:56 Key updates at ASCO GI 2022 00:41 ASCO GI 2023 highlights 38:51 ASCO 2022: Highlights and analysis 01:26 Updates from ASCO GI: 2023 West Oncology 01:10 Highlights in bladder cancer from ASCO 2022 03:01 The Latest Lung Cancer Research Updates From ASCO 2022 00:39 Highlights at ASCO 2023 01:02 Key takeaways from ASCO 2022 04:35 Highlights from ASCO GU 2022 01:24 What to look forward to at ASCO GI 2022 14:50 GI ASCO 2022 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Mark Lewis 00:54 Highlights in GI cancer at ASCO 2022 21:40 Bladder Cancer Conference Highlights from ASCO 2022 32:57 2022 ASCO GI Cancers Symposium Keynote: Precision Medicine, AI and Innovation 01:27 Takeaways in hepatocellular carcinoma at ASCO GI 2023 More results